Investor Calendar Invites You to the Imprimis Pharmaceuticals Second Quarter 2016 Earnings Conference Call and Webcast Live on Monday, August 15, 2016

SAN DIEGO, CA / ACCESSWIRE / August 15, 2016 / Imprimis Pharmaceuticals, Inc. IMMY will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held Monday, August 15, 2016 at 4:30 PM Eastern Time.

To participate in this event, dial 877-407- 8035 domestically, or 201-689- 8035 internationally, approximately 5 to 10 minutes before the beginning of the call. Additionally, you can listen to the event online at www.investorcalendar.com/IC/CEPage.asp?ID=175190 or the Imprimis Pharmaceuticals website (www.imprimispharma.com).

If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com or www.imprimispharma.com.

You may access the teleconference replay by dialing 877-660-6853 domestically or 201-612-7415 internationally, referencing conference ID # 13641964. The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on September 15, 2016.

About Imprimis Pharmaceuticals

Imprimis Pharmaceuticals, Inc. (IMMY) is a pharmaceutical company dedicated to making drugs affordable again through its Branded Compounding™ business model. The company is focused on patient outcomes and affordability and offers high quality lower-cost custom compounded drugs in all 50 states. Headquartered in San Diego, California, Imprimis owns and operates four dispensing facilities located in California, Texas, New Jersey and Pennsylvania. For more information about Imprimis, please visit the corporate website at www.ImprimisPharma.com.

SOURCE: Investor Calendar